Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-13

Clinical Trial Update: Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study [Phase 1]

View source ↗

Summary

University of Alberta is conducting a Phase 1 pilot trial to evaluate the health effects of an egg-derived bioactive peptide, currently recruiting, on hyperglyc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Egg-derived bioactive peptide (bioactive egg peptide)

Snippet

Sponsor: University of Alberta | Conditions: High Blood Sugar, High Blood Pressure | Phase 1 | Status: RECRUITING